These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 20332413

  • 1. Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients.
    Aparecida da Silva M, Cordeiro Q, Louzã M, Vallada H.
    J Atten Disord; 2011 May; 15(4):305-9. PubMed ID: 20332413
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD.
    Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, Scheffer H, Kiemeney LA, Kan CC, Kooij JJ, Buitelaar JK.
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec 05; 147B(8):1576-9. PubMed ID: 18802924
    [Abstract] [Full Text] [Related]

  • 6. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
    Shang CY, Gau SS, Liu CM, Hwu HG.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):421-8. PubMed ID: 20800641
    [Abstract] [Full Text] [Related]

  • 7. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.
    Tong JH, Cummins TD, Johnson BP, McKinley LA, Pickering HE, Fanning P, Stefanac NR, Newman DP, Hawi Z, Bellgrove MA.
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar 30; 168B(2):89-96. PubMed ID: 25656223
    [Abstract] [Full Text] [Related]

  • 8. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder.
    Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY.
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun 05; 144B(4):541-50. PubMed ID: 17440978
    [Abstract] [Full Text] [Related]

  • 9. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).
    Feng Y, Wigg KG, Makkar R, Ickowicz A, Pathare T, Tannock R, Roberts W, Malone M, Kennedy JL, Schachar R, Barr CL.
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov 05; 139B(1):1-6. PubMed ID: 16082693
    [Abstract] [Full Text] [Related]

  • 10. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder.
    Simsek M, Al-Sharbati M, Al-Adawi S, Lawatia K.
    Genet Test; 2006 Nov 05; 10(1):31-4. PubMed ID: 16545000
    [Abstract] [Full Text] [Related]

  • 11. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M.
    Arch Gen Psychiatry; 2007 May 05; 64(5):585-90. PubMed ID: 17485610
    [Abstract] [Full Text] [Related]

  • 12. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C, Faraone SV, Scassellati C.
    Mol Psychiatry; 2016 Jul 05; 21(7):872-84. PubMed ID: 27217152
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J, Romanos M, Ettinger U.
    Pharmacogenomics J; 2014 Feb 05; 14(1):77-84. PubMed ID: 23588108
    [Abstract] [Full Text] [Related]

  • 14. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.
    Grünblatt E, Werling AM, Roth A, Romanos M, Walitza S.
    J Neural Transm (Vienna); 2019 Apr 05; 126(4):517-529. PubMed ID: 30923918
    [Abstract] [Full Text] [Related]

  • 15. A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.
    Genro JP, Polanczyk GV, Zeni C, Oliveira AS, Roman T, Rohde LA, Hutz MH.
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec 05; 147B(8):1568-75. PubMed ID: 18802919
    [Abstract] [Full Text] [Related]

  • 16. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
    de Azeredo LA, Rovaris DL, Mota NR, Polina ER, Marques FZ, Contini V, Vitola ES, Belmonte-de-Abreu P, Rohde LA, Grevet EH, Bau CH.
    Eur Arch Psychiatry Clin Neurosci; 2014 Aug 05; 264(5):401-8. PubMed ID: 24487615
    [Abstract] [Full Text] [Related]

  • 17. DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy.
    Mignini F, Napolioni V, Codazzo C, Carpi FM, Vitali M, Romeo M, Ceccanti M.
    Neurosci Lett; 2012 Aug 01; 522(2):103-7. PubMed ID: 22698582
    [Abstract] [Full Text] [Related]

  • 18. The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD.
    Kuc K, Bielecki M, Racicka-Pawlukiewicz E, Czerwinski MB, Cybulska-Klosowicz A.
    Sci Rep; 2020 Apr 10; 10(1):6176. PubMed ID: 32277231
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA, García-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernández JM, Alvarez V, Coto E, Bascarán MT, Bousoño M, Fañanas L, Bobes J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):26-31. PubMed ID: 19766158
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T, Rohde LA, Hutz MH.
    Am J Pharmacogenomics; 2004 Feb 01; 4(2):83-92. PubMed ID: 15059031
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.